1. Home
  2. PLRX vs ACIC Comparison

PLRX vs ACIC Comparison

Compare PLRX & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • ACIC
  • Stock Information
  • Founded
  • PLRX 2015
  • ACIC 1999
  • Country
  • PLRX United States
  • ACIC United States
  • Employees
  • PLRX N/A
  • ACIC N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • ACIC Property-Casualty Insurers
  • Sector
  • PLRX Health Care
  • ACIC Finance
  • Exchange
  • PLRX Nasdaq
  • ACIC Nasdaq
  • Market Cap
  • PLRX 680.3M
  • ACIC 588.1M
  • IPO Year
  • PLRX 2020
  • ACIC N/A
  • Fundamental
  • Price
  • PLRX $11.77
  • ACIC $12.05
  • Analyst Decision
  • PLRX Strong Buy
  • ACIC Buy
  • Analyst Count
  • PLRX 7
  • ACIC 1
  • Target Price
  • PLRX $40.50
  • ACIC $16.00
  • AVG Volume (30 Days)
  • PLRX 485.5K
  • ACIC 156.1K
  • Earning Date
  • PLRX 02-26-2025
  • ACIC 02-27-2025
  • Dividend Yield
  • PLRX N/A
  • ACIC 4.18%
  • EPS Growth
  • PLRX N/A
  • ACIC N/A
  • EPS
  • PLRX N/A
  • ACIC 1.76
  • Revenue
  • PLRX N/A
  • ACIC $290,784,000.00
  • Revenue This Year
  • PLRX N/A
  • ACIC N/A
  • Revenue Next Year
  • PLRX N/A
  • ACIC $12.68
  • P/E Ratio
  • PLRX N/A
  • ACIC $6.77
  • Revenue Growth
  • PLRX N/A
  • ACIC 1.02
  • 52 Week Low
  • PLRX $10.22
  • ACIC $8.82
  • 52 Week High
  • PLRX $18.00
  • ACIC $15.08
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 47.63
  • ACIC 38.82
  • Support Level
  • PLRX $10.35
  • ACIC $11.81
  • Resistance Level
  • PLRX $11.07
  • ACIC $12.66
  • Average True Range (ATR)
  • PLRX 0.55
  • ACIC 0.29
  • MACD
  • PLRX 0.11
  • ACIC -0.01
  • Stochastic Oscillator
  • PLRX 55.75
  • ACIC 11.76

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About ACIC American Coastal Insurance Corporation

American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary. The company has two segments namely: Commercial Lines Business and Personal Lines Business. It derives maximum revenue from Commercial Lines Business Segment.

Share on Social Networks: